住友ファーマJP:4506損益計算書

時価総額
¥1.16兆
PER
12.6倍
医療用医薬品の製造・販売を中心に、再生・細胞医薬分野の開発受託や研究開発を手がける企業。
2012/032013/032014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
売上高350,395347,724387,693371,370403,206411,638477,966459,267482,732515,952560,035555,544314,558398,832
売上原価---101,227104,470100,07866,590113,553129,673137,773157,127178,919126,577153,437
売上総利益---270,142298,736311,560184,511345,714353,059378,179402,908376,625187,981245,395
売上総利益率(%)---
営業利益---23,27536,92952,75974,56857,88483,23971,22460,234-76,979-354,85928,804
営業費用---246,867261,805258,808109,943180,439154,348190,373249,081373,316429,538180,605
経常(税引前)利益18,87224,50540,63123,33135,22154,34184,86665,04683,94777,85182,961-47,920-323,11417,611
法人税等合計---18,30714,86318,22617,18016,41948,02941,02242,36148,794-8,185-6,024
純利益22,05811,35615,21015,44724,69728,99153,44848,62740,75356,21956,413-74,512-314,96923,634
一株あたり利益21.7225.2850.4938.8862.1672.97134.53122.39102.58141.5141.99-187.55-792.7959.49
一株あたり配当金181818181820282828282821--